|
Discovery of Alpha-MSH Analogs for Skin Cancer Prevention
|
5R01CA114095-03
|
$300,311
|
|
ABDEL-MALEK, ZALFA
|
UNIVERSITY OF CINCINNATI
|
|
PHASE I SINGLE AND MULTIPLE-DOSE SAFETY AND PHARMACOKINETIC CLINICAL STUDY OF LYC
|
N01CN085081-008
|
|
|
ABEITA, CATHY
|
University of Illinois at Chicago
|
|
Multiphoton microscopy using near infrared Dyes
|
4R33CA123537-02
|
$462,439
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Biophysical studies of oncogenic Cdc42Hs constructs
|
5K01CA113753-02
|
$116,888
|
|
ADAMS, PAUL
|
UNIVERSITY OF ARKANSAS AT FAYETTEVILLE
|
|
Functional determinants of metastatic dormancy
|
7R01CA109182-05
|
$303,516
|
|
AGUIRRE-GHISO, JULIO
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach (1 of 2
|
5U54CA137788-10
|
$1,469,019
|
$176,282
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Chemoprevention of arsenic-induced skin cancer
|
5R01CA107431-04
|
$1,511,506
|
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
Genomewide association in early-onset breast cancer
|
5U01CA122171-03
|
$1,170,110
|
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
Epidemiologic Studies of Techa River Cohorts
|
N01CP045505-000
|
$105,573
|
|
AKLEYEV, ALEXANDER
|
Urals Research Center for Radiation Mede
|
|
Corn Farming Study
|
Z01 CP010119-02075
|
$9,986
|
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Gastric cancer in Eastern Nebraska case-control study
|
Z01 CP010119-02200
|
$7,156
|
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Brain cancer in Eastern Nebraska case-control study
|
Z01 CP010119-02210
|
$12,528
|
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Genomic and Functional Analysis of Oral Cancer Development
|
5R01CA118323-02
|
$270,375
|
|
Albertson, Donna
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Lanthanide Radionuclide Production
|
1R41CA105743-01A1
|
$179,250
|
|
ALFORD, JOHN
|
TDA RESEARCH, INC.
|
|
Novel Targeted Therapeutics for Cental Nervous System Malignancies
|
5R01CA112519-03
|
$327,069
|
|
Ali-Osman, Francis
|
DUKE UNIVERSITY
|
|
Deformable registration for image-guided radiotherapy
|
5F32CA124138-02
|
$46,826
|
|
Alterovitz, Ron
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Video Rate Optical Coherence Tomography for Early Stage Cancer Visualization
|
4R44CA123920-02
|
$1,224,796
|
|
AMAZEEN, PAUL
|
IMALUX CORPORATION
|
|
Statistical Methods for Gene Environment Interactions In Lung Cancer
|
5R01CA133996-02
|
$263,340
|
|
AMOS, CHRISTOPHER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Multi-Targeted Contrast Ultrasound Agent for Imaging Angiogenesis
|
1R43CA137913-01
|
$104,679
|
|
Anderson, Christopher
|
TARGESON, LLC
|
|
SPORE in Myeloma
|
2P50CA100707-06
|
$2,300,000
|
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Chemoprevention of Lung Cancer
|
3P01CA096964-05S1
|
$12,264
|
|
ANDERSON, MARSHALL
|
UNIVERSITY OF CINCINNATI
|
|
Chemoprevention of Lung Cancer
|
3P01CA096964-05S2
|
$307,468
|
|
ANDERSON, MARSHALL
|
UNIVERSITY OF CINCINNATI
|
|
Mechanisms in Perinatal Carcinogenesis
|
Z01 BC 005352
|
$546,189
|
|
Anderson, Lucy
|
CCR (NCI)
|
|
Mechanistic Targeting of Lung Cancer
|
Z01 BC 005399
|
$546,189
|
|
Anderson, Lucy
|
CCR (NCI)
|
|
Molecular Studies of Cellular Cytotoxicity
|
Z01 BC 010013
|
$567,261
|
|
Anderson, Stephen
|
CCR (NCI)
|
|
General Descriptive Studies
|
Z01 CP010183-00350
|
$156,344
|
|
Anderson, William
|
DCEG (NCI)
|
|
Swedish childhood cancers study
|
Z01 CP010183-00550
|
$2,170
|
|
Anderson, William
|
DCEG (NCI)
|
|
Swedish CER occupational study
|
Z01 CP010183-02050
|
$10,053
|
|
Anderson, William
|
DCEG (NCI)
|
|
Childhood Cancers among Children with Birth Defects in California
|
Z01 CP010183-10459
|
$128,276
|
|
Anderson, William
|
DCEG (NCI)
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$791,415
|
$158,283
|
Anderson, Stephen
|
CCR (NCI)
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025516-089
|
$1,929,112
|
|
ANDRIOLE, GERALD
|
WASHINGTON UNIV:1107522
|
|
Elimination of Carcinogen-Induced Tumor Stem Cells by ATF5 Loss of Function.
|
1R21CA126924-01A2
|
$171,000
|
|
Angelastro, James
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules
|
1R01CA133508-01A1
|
$304,917
|
|
ANSARI, ASEEM
|
UNIVERSITY OF WISCONSIN MADISON
|
|
The role of antigen-specific CD4+ T cells during immunity to established tumors
|
3K22CA125200-02S1
|
$44,831
|
|
Antony, Paul
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
The role of antigen-specific CD4+ T cells during immunity to established tumors
|
5K22CA125200-03
|
$161,730
|
|
Antony, Paul
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Collaborative Pathways that Lead to Leukemia
|
Z01 BC 010982
|
$258,071
|
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$258,071
|
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
Z01 SC 010379
|
$258,071
|
|
Aplan, Peter
|
CCR (NCI)
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$380,330
|
$190,165
|
Aplan, Peter
|
CCR (NCI)
|
|
B-RAF Regulation of the Cell Cycle in Melanoma
|
1R01CA125103-01A2
|
$287,568
|
|
APLIN, ANDREW
|
ALBANY MEDICAL COLLEGE
|
|
Inflammatory Markers in Circulation and Ovarian Cancer Risk
|
1R21CA116585-01A1
|
$190,688
|
|
Arslan, Alan
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-08S1
|
$175,000
|
$5,250
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-08
|
$2,480,000
|
$74,400
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
|
Z01 BC 010692
|
$64,298
|
|
Arthur, Diane
|
CCR (NCI)
|
|
Resident and Preceptor Education in Nutrition and Cancer
|
1R25CA127432-01A1
|
$320,405
|
|
ASHLEY, JUDITH
|
UNIVERSITY OF NEVADA RENO
|
|
T Cell Alternative p38 Activation Pathway
|
Z01 BC 010774
|
$431,955
|
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Regulation and Consequences of Ubiquitination
|
Z01 BC 010779
|
$431,955
|
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
Z01 BC 011004
|
$89,029
|
|
Avital, Itzhak
|
CCR (NCI)
|
|
Protooncogenes-Signaling in Development and Neoplasia
|
5P01CA023767-29
|
$1,075,894
|
|
AXEL, RICHARD
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
In Vitro Assay for Chemical Allergens
|
5R44CA106137-03
|
$438,697
|
|
AYEHUNIE, SEYOUM
|
MATTEK CORPORATION
|
Total relevant funding to Organ Transplantation Research for this search: $47,380,371
|